Markets dipped on Tuesday, with the S&P 500 facing its third consecutive decline, largely driven by rising interest rates and persistent energy price pressures. The 10-year Treasury yield surged to 4.665%, while the 30-year yield reached a 19-year high of 5.19%. This uptick in yields has raised concerns about inflation and its potential to dampen consumer spending, as evidenced by Home Depot’s disappointing earnings. Defensive sectors, particularly healthcare, saw increased buying interest as investors sought stability amid market volatility.

Eli Lilly’s shares gained over 2% following positive insights from a Citigroup survey on oral GLP-1 medications, suggesting a robust growth trajectory for its product Foundayo. Analysts project sales could reach $2.8 billion by 2026, significantly outpacing current expectations. The survey indicates that physicians are favoring Foundayo’s ease of use over Novo Nordisk’s Wegovy, which has stricter administration requirements, potentially positioning Lilly to capture more market share.

As earnings reports loom from major retailers like TJX Companies and Target, market participants should monitor how these results reflect consumer sentiment and spending trends, especially in the context of rising rates and inflationary pressures.

Source: cnbc.com